Intermolecular (IMI) IPO Opens Flast
Tweet
Share
E-mail
The IPO for Intermolecular, Inc. (Nasdaq: IMI) opened for trading at $10 after pricing 9,650,000 shares $10 per share, which was well below the expected $12-$14 range. Shares have since traded down to $9.60.
Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Barclays Capital Inc. are acting joint book-running managers for the offering.
42,256,487 shares are expected to be outstanding after this offering, or 43,665,815 shares if the underwriters exercise their over-allotment option in full.
Intermolecular has pioneered a proprietary approach to accelerate research and development, innovation, and time-to-market for the semiconductor and clean-energy industries.
Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Barclays Capital Inc. are acting joint book-running managers for the offering.
42,256,487 shares are expected to be outstanding after this offering, or 43,665,815 shares if the underwriters exercise their over-allotment option in full.
Intermolecular has pioneered a proprietary approach to accelerate research and development, innovation, and time-to-market for the semiconductor and clean-energy industries.
Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!
Create E-mail Alert Related Categories
IPOsRelated Entities
JPMorgan, Morgan Stanley, BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
